跳至主要内容
临床试验/TCTR20190223001
TCTR20190223001招募中未知

Early versus Late Allopurinol Initiation in an Acute Gout Attack: A Randomized Controlled Trial (ELAG)

avamindradhiraj University Research Fund0 个研究点目标入组 114 人开始时间: 2019年2月23日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
114

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • Patients > 18 years old presented with an acute gout attack within 72 hours after onset, and crystal-proven gout by arthrocentesis founded MSU crystals
  • and at least one of the following
  • - Frequent attack ≥ 2/year, tophi by clinical exam or imaging study, CKD stage 2 or worse (Estimated Glomerular Filtration Rate < 90 ml/min/1.73m2 ), past urolithiasis, serum uric acid > 8 mg/dL during attack or comorbidities (at least one of following; hypertension, ischemic heart disease or congestive heart failure)

排除标准

  • 1. CKD stage 5 (eGFR < 15) or on Renal replacement therapy
  • 2. Prior use of uric lowering agents past month
  • 3. History of adverse reactin to allopurinol or colchicine
  • 3. Ongoing cancer treatment
  • 4. concomitant use of azathioprine or cyclosporin
  • 5. taking xanthine oxidase inhibitor or uricosuric agent withih 1 month
  • 6. AST, ALTand/or ALP level more than 2 times of upper normal limit
  • 7. Neurologic deficit resulting in decreased pain sensatin around the involve joints
  • 8. During intubation
  • 9. Inability to return for examinations
  • 10. presence of HLA-B*5801 genes

研究者

发起方
avamindradhiraj University Research Fund

相似试验

Early versus Late Allopurinol Initiation in an Acute... | 临床试验